14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jan 12, 2024 Buy 0 Schoch Charles Common Stock
Jan 12, 2024 Buy 0 Schoch Charles Common Stock
Jan 12, 2024 Buy 25 000 Schoch Charles Stock Option (Right to Buy)
Jan 12, 2024 Buy 39 498 Schoch Charles Stock Option (Right to Buy)
Nov 28, 2023 Sell 17 328 Tyagarajan Seshu Common Stock
Nov 28, 2023 Sell 43 443 Tak Paul Peter Common Stock
Nov 28, 2023 Sell 12 175 Nichols William Garrett Common Stock
Nov 28, 2023 Sell 19 748 Barone Francesca Common Stock
Nov 28, 2023 Sell 20 153 Amello Jason Common Stock
Nov 26, 2023 Buy 180 108 Tak Paul Peter Common Stock
Nov 26, 2023 Buy 104 516 Tyagarajan Seshu Common Stock
Nov 26, 2023 Buy 88 822 Nichols William Garrett Common Stock
Nov 26, 2023 Buy 112 790 Barone Francesca Common Stock
Nov 26, 2023 Buy 125 717 Amello Jason Common Stock
Jun 28, 2023 Buy 14 240 Gaeta Renee Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Nguyen Diem Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Manning Paul B Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Martell Christopher Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Benz Edward J. Jr Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Papa Joseph C Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Aguilar-cordova Estuardo Stock Option (Right to Buy)
Jun 28, 2023 Buy 14 240 Nabel Gary J. Stock Option (Right to Buy)
Jun 07, 2023 Buy 28 480 Loggia Nicoletta Stock Option (Right to Buy)
Jun 07, 2023 Buy 0 Loggia Nicoletta
Apr 28, 2023 Buy 180 000 Tak Paul Peter Stock Option (Right to Buy)
Apr 28, 2023 Buy 90 000 Tyagarajan Seshu Stock Option (Right to Buy)
Apr 28, 2023 Buy 45 000 Nichols William Garrett Stock Option (Right to Buy)
Apr 28, 2023 Buy 90 000 Barone Francesca Stock Option (Right to Biuy)
Apr 28, 2023 Buy 90 000 Amello Jason Stock Option (Right to Buy)
Dec 09, 2022 Buy 23 950 Martell Christopher Common Stock
Dec 09, 2022 Buy 35 018 Papa Joseph C Common Stock
Dec 09, 2022 Buy 23 950 Martell Christopher Common Stock
Dec 09, 2022 Buy 12 935 Tak Paul Peter Common Stock
Dec 09, 2022 Buy 10 358 Tyagarajan Seshu Common Stock
Dec 09, 2022 Buy 2 468 Amello Jason Common Stock
Dec 08, 2022 Buy 3 050 Martell Christopher Common Stock
Dec 08, 2022 Buy 1 238 Barone Francesca Common Stock
Dec 08, 2022 Buy 3 014 Papa Joseph C Common Stock
Dec 08, 2022 Buy 3 050 Martell Christopher Common Stock
Dec 08, 2022 Buy 3 050 Tak Paul Peter Common Stock
Dec 08, 2022 Buy 3 000 Tyagarajan Seshu Common Stock
Dec 08, 2022 Buy 3 100 Amello Jason Common Stock
Nov 28, 2022 Buy 90 877 Amello Jason Common Stock
Nov 28, 2022 Buy 195 906 Tak Paul Peter Common Stock
Nov 28, 2022 Buy 90 877 Barone Francesca Common Stock
Nov 28, 2022 Buy 58 479 Nichols William Garrett Common Stock
Nov 28, 2022 Buy 73 684 Tyagarajan Seshu Common Stock
Oct 13, 2022 Buy 14 240 Aguilar-cordova Estuardo Stock Option (Right to Buy)
Oct 13, 2022 Buy 14 240 Nguyen Diem Stock Option (Right to Buy)
Oct 13, 2022 Buy 14 240 Martell Christopher Stock Option (Right to Buy)
Oct 13, 2022 Buy 14 240 Benz Edward J. Jr Stock Option (Right to Buy)
Oct 13, 2022 Buy 14 240 Manning Paul B Stock Option (Right to Buy)
Sep 21, 2022 Buy 230 000 Amello Jason Stock Option (Right to Buy)
Sep 21, 2022 Buy 0 Amello Jason
Sep 12, 2022 Buy 200 000 Nichols William Garrett Stock Option (Right to Buy)
Sep 12, 2022 Buy 0 Nichols William Garrett
Aug 08, 2022 Buy 28 480 Gaeta Renee Stock Option (Right to Buy)
Aug 08, 2022 Buy 28 480 Gaeta Renee Stock Option (Right to Buy)
Aug 08, 2022 Buy 28 480 Nabel Gary J. Stock Option (Right to Buy)
Aug 08, 2022 Buy 28 480 Papa Joseph C Stock Option (Right to Buy)
Aug 08, 2022 Buy 28 480 Papa Joseph C Stock Option (Right to Buy)
Aug 08, 2022 Buy 0 Papa Joseph C
Aug 08, 2022 Buy 0 Gaeta Renee
Aug 08, 2022 Buy 0 Nabel Gary J.
May 06, 2022 Sell 68 534 Aguilar Laura K. Common Stock
May 06, 2022 Sell 76 717 Aguilar Laura K. Stock Option (Right to Buy)
May 06, 2022 Sell 54 074 Aguilar-cordova Estuardo Common Stock
May 06, 2022 Sell 12 205 Aguilar-cordova Estuardo Stock Option (Right to Buy)
Apr 14, 2022 Buy 120 000 Tyagarajan Seshu Stock Option (Right to Buy)
Apr 14, 2022 Buy 0 Tyagarajan Seshu
Apr 11, 2022 Buy 20 000 Stewart Susan B. Stock Option (Right to Buy)
Feb 28, 2022 Buy 110 000 Canepa John J Stock Option (Right to Buy)
Feb 28, 2022 Buy 330 000 Tak Paul Peter Stock Option (Right to Buy)
Feb 28, 2022 Buy 110 000 Barone Francesca Stock Option (Right to Buy)
Feb 03, 2022 Buy 40 000 Barone Francesca Stock Option (Right to Buy)
Feb 03, 2022 Buy 0 Barone Francesca Common Stock
Feb 03, 2022 Buy 48 822 Barone Francesca Stock Option (Right to Buy)
Dec 31, 2021 Sell 0 Manning Paul B Common Stock
Dec 31, 2021 Buy 0 Manning Paul B Common Stock
Jul 29, 2021 Buy 1 625 000 Manning Paul B Common Stock
Jul 29, 2021 Buy 679 158 Manning Paul B Common Stock
Jul 29, 2021 Buy 553 752 Manning Paul B Common Stock
Jul 29, 2021 Sell 1 361 069 Manning Paul B Series B Preferred Stock
Jul 29, 2021 Buy 283 514 Martell Christopher Common Stock
Jul 29, 2021 Buy 125 000 Martell Christopher Common Stock
Jul 29, 2021 Sell 696 851 Martell Christopher Series B Preferred Stock
Jul 29, 2021 Buy 162 137 Aguilar-cordova Estuardo Common Stock
Jul 29, 2021 Sell 398 519 Aguilar-cordova Estuardo Series B Preferred Stock
Jul 29, 2021 Buy 10 000 Nguyen Diem Common Stock
Jul 29, 2021 Buy 25 000 Tak Paul Peter Common Stock
Jul 29, 2021 Buy 679 158 Manning Paul B Common Stock
Jul 29, 2021 Buy 553 752 Manning Paul B Common Stock
Jul 29, 2021 Sell 1 361 069 Manning Paul B Series B Preferred Stock
Jul 29, 2021 Buy 10 125 Canepa John J Common Stock
Jul 29, 2021 Buy 56 096 Aguilar Laura K. Common Stock
Jul 29, 2021 Sell 137 881 Aguilar Laura K. Series B Preferred Stock
Jul 29, 2021 Buy 6 000 Caffo Nathan Common Stock
Jul 29, 2021 Buy 20 000 Manning Paul B Common Stock
Jul 26, 2021 Buy 28 480 Nguyen Diem Stock Option (Right to Buy)
Jul 26, 2021 Buy 28 840 Nguyen Diem Stock Option (Right to Buy)
INSIDER POWER
71.913
Last 100 transactions
Buy: 8 220 289 | Sell: 4 279 766 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 71.913.

In total, the insiders bought 8 220 289 and sold 4 279 766 CADL shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Candel Therapeutics, Inc.

Candel Therapeutics. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi... CADL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT